Objective To explore the risk factors of chronic kidney disease (CDK) in premature infants and low birth weight infants. Methods Cases of low birth weight and premature infants from three key hospitals in Sanya, Hainan Province were collected in this study from January 2005 to January 2019. All traceable children were followed up for 18 months to observe the screening rate of CKD. The clinical data after birth, the laboratory examination data after enrollment and the results of follow-up data were analyzed. Logistic regression analysis was used to observe the risk factors of CKD in preterm and low birth weight infants. ROC curve analysis was used to observe the effectiveness of each risk factor in evaluating CKD. Results A total of 1 269 subjects were included in the study, of whom 39(3.07%) cases were diagnosed with CKD. Binary Logistic regression analysis showed that gestational age ≥29.37 weeks, endogenous creatinine clearance (Ccr)≤36.53 ml/(min·1.73 m2), serum albumin≥39.43 g/L, and exercise behavior index≥10.17 were the protective factors for preterm infants and low birth weight infants from CKD (β=-0.290,-0.117,-0.038,-0.559,P<0.05), serum creatinine (Scr)≥47.58 μmol/L, diastolic blood pressure≥85.69 mmHg, urine albumin≥12.16 mg/L, fasting blood glucose≥5.61 mmol/L were risk factors for CKD in preterm infants and low birth weight infants (β=0.047,0.069,0.315,1.510,P<0.05). ROC analysis showed that Ccr, serum albumin, diastolic blood pressure, blood creatinine, urine albumin, fasting blood glucose, and exercise behavior index had certain value in predicting CKD in preterm infants and low birth weight infants (P<0.05), and Ccr and Scr had better predictive performance (AUC =0.794,0.738). Conclusions Scr diastolic blood pressure, urine albumin, and fasting blood glucose are risk factors for CKD in preterm infants and low birth weight infants. High exercise index, high serum albumin, and high gestational age are beneficial to reduce CKD in premature and low birth weight infants. Ccr and Scr can predict the occurrence of CKD in preterm infants and low birth weight infants, but attention should be paid to the identification of false positive cases.
Key words
chronic kidney disease /
premature /
low birth weight infants /
serum creatinine
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease[J]. Hemodial Int, 2018, 22(2):150-160.
[2] Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease[J]. Nat Rev Nephrol, 2017, 13(5):269-284.
[3] Fathallah-Shaykh SA. Proteinuria and progression of pediatric chronic kidney disease:lessons from recent clinical studies[J]. Pediatr Nephrol, 2017, 32(5):743-751.
[4] 王芳,王海燕.慢性肾脏病定义、诊断及分期的新探讨[J].中华内科杂志,2010,49(9):729-730.
[5] 王学晶. 儿童肾小球滤过率的评估方法[J]. 中华儿科杂志, 2016,54(7):539-542.
[6] Baum M. Progression of chronic kidney disease in children[J].Curr Opin Pediatr, 2018, 30(2):216-219.
[7] 曹静,谢院生.早产儿和出生低体重儿肾损害的易感性及发生机制[J].中华肾病研究电子杂志,2017,6(2):88-91.
[8] Liu K, Zhou S, Liu J, et al.Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy[J]. Drug Des Devel Ther, 2019,29(13):3117-3126.
[9] Luyckx VA, Brenner BM. Birth weight, malnutrition and kidney-associated outcomes-a global concern[J]. Nat Rev Nephrol, 2015, 11(3):135-149.
[10] Abitbol CL, Moxey-Mims M. Chronic kidney disease:Low birth weight and the global burden of kidney disease[J]. Nat Rev Nephrol, 2016, 12(4):199-200.
[12] Esmeijer K, de Vries AP, Mook-Kanamori DO, et al. Low birth weight and kidney function in middle-aged men and women:the netherlands epidemiology of obesity study[J].Am J Kidney Dis, 2019,74(6):751-760.
[13] 张若林, 帅兰军, 李晓燕, 等. 出生体重与慢性肾脏病关联性的系统评价和Meta分析[J]. 中国循证儿科杂志, 2017, 12(2):93-99.
[14] Das SK,Mannan M, Faruque ASG, et al. Effect of birth weight on adulthood renal function:A bias-adjusted meta-analytic approach[J]. Nephrology, 2016, 21(7):547-565.
[15] Girndt M.Diagnosis and treatment of chronic kidney disease[J].Internist (Berl), 2017,58(3):243-256.
[16] 赵璐,梅长林,邬碧波,等.上海市静安区慢性肾脏病高危人群社区筛查结果分析[J].中华肾脏病杂志,2020,36(1):1-5.
[17] 冯晋,张爱华.慢性肾脏病合并高血压的新机制[J].中华肾病研究电子杂志,2020,9(1):33-37.
[18] 刘旭利,程庆砾,高军,等.北京城区军队高龄男性代谢综合征与慢性肾脏病的相关性研究[J].中华保健医学杂志,2020,22(2):169-172.
[19] 张晓蕾,贾鸿雁.早期慢性肾脏病患者社区-家庭-自我管理近远期效果分析[J].中国全科医学,2020,23(11):1361-1367.
[20] 王世农.血清胱抑素-C、血清肌酐与尿微量白蛋白联合检测在慢性肾病临床诊断中意义[J].中国实验诊断学,2013,17(3):545-546.